This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

PPD Announces 2011 PPD Beach2Battleship Triathlon Heroes

Stocks in this article: PPDI

PPD, Inc. (Nasdaq: PPDI) today announced the 2011 PPD Heroes team, featuring cancer survivors and medical specialists competing as triathletes in the PPD Beach2Battleship Triathlon on Oct. 29. The PPD Heroes are helping raise public awareness about the value of participating in clinical trials in the development of life-changing medicines.

For people facing illness, participating in a clinical trial can offer new opportunities for cutting-edge treatment and close medical supervision. Increasing the number of patients who participate in clinical trials can help accelerate research into new medical treatments.

“We are proud to sponsor this premier triathlon, and we are pleased to introduce the 2011 team of PPD Heroes,” said Ray Hill, CEO of PPD. “We look forward to welcoming them to Wilmington, home of PPD’s global headquarters, and cheering them on during race day. They are an inspiration to us all.”

The 2011 team of PPD Heroes includes:

  • Kristen Adelman, a four-time non-Hodgkin’s lymphoma survivor who participated in a clinical trial that she says saved her life. “The care I received was the absolute best,” she said, “and the team of doctors and nurses was incredible.”
  • Claudio Battaglini, Ph.D., a professor conducting research on the effects of exercise training in mitigating side effects of anti-cancer treatments. “Without clinical trials,” he said, “it is virtually impossible to test new interventions to improve the quality of our lives.”
  • Wendy Chioji, who was diagnosed with stage II breast cancer and participated in a clinical trial in part to help reduce the suffering of others in the future. “Before I even knew if I would get better,” she said, “participating in a clinical trial was a way for me to pay it forward.”
  • Roseann Dougherty, who at age 10 lost her mother to brain cancer and went on to become an oncology nurse and start a nonprofit organization to provide healing resources for cancer patients. “Clinical trials can provide hope and new treatments,” she said.
  • Mary Kreis, Ph.D., who learned she was pregnant and had melanoma during a cross-country bike ride. Through a clinical trial, she underwent surgeries during her pregnancy and gave birth to a healthy baby girl named Viva to symbolize living life to the fullest. “Without clinical trials,” Kreis said, “my cancer may have been missed."

The PPD Beach2Battleship Triathlon has been ranked one of the top five triathlons in the world by Triathlete magazine . Approximately 1,875 triathletes from 43 U.S. states and five other nations are converging in Wilmington and Wrightsville Beach, N.C., for the event. It is expected to generate approximately $3.9 million in local economic impact. Funds raised from the event will benefit the Wilmington Family YMCA.

The iron distance triathlon includes a 2.4-mile swim, a 112-mile bike ride and a 26.2-mile run, and the event also offers a half-triathlon course. The race starts in Wrightsville Beach, winds through New Hanover, Pender, Sampson and Bladen counties and ends at the USS North Carolina Battleship Memorial in downtown Wilmington.

1 of 3

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs